F. Cetinkaya, Hatice Karagoz, Orhan Yıldız, Ic Hastaliklari Klinigi Kayseri Turkiye Acibadem Kayseri Hastanesi
{"title":"Comparison of Liver Safety of Favipiravir and Hydroxychloroquine in COVID-19 Treatment","authors":"F. Cetinkaya, Hatice Karagoz, Orhan Yıldız, Ic Hastaliklari Klinigi Kayseri Turkiye Acibadem Kayseri Hastanesi","doi":"10.5152/kd.2020.49","DOIUrl":null,"url":null,"abstract":"Objective: Since the first case from Wuhan, China in December 2019, COVID-19 has spread all over the world and a pandemic was declared by the World Health Organization on January 30, 2020 While there are no specific effective antiviral drugs or vaccines to treat or to prevent COVID-19;favipiravir, hydroxychloroquine and their combination are used in the treatment of COVID-19 in Turkey In this study, it was aimed to evaluate the demographic, clinical and laboratory findings, the treatments given and the effects of treatments on liver tests of the patients followed up with the diagnosis of COVID-19","PeriodicalId":17826,"journal":{"name":"Klimik Dergisi/Klimik Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klimik Dergisi/Klimik Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/kd.2020.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Objective: Since the first case from Wuhan, China in December 2019, COVID-19 has spread all over the world and a pandemic was declared by the World Health Organization on January 30, 2020 While there are no specific effective antiviral drugs or vaccines to treat or to prevent COVID-19;favipiravir, hydroxychloroquine and their combination are used in the treatment of COVID-19 in Turkey In this study, it was aimed to evaluate the demographic, clinical and laboratory findings, the treatments given and the effects of treatments on liver tests of the patients followed up with the diagnosis of COVID-19
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
